University of Edinburgh biotechnology spinout Pheno Therapeutics has announced its lead therapeutic candidate has been cleared as an Investigational New Drug (IND) by the US Food and Drug Administration (FDA), allowing it to move to healthy volunteer studies.
Around 170 academic, industry and public sector partners came together this week for Edinburgh Innovations’ annual Fast Forward conference, this year on the theme of ‘Data, digital and AI: The future beyond the hype’.
University of Edinburgh startup Aveni, a leading AI specialist in wealth management, financial advice and banking, today announced £12 million raised in its latest funding round.
The University of Edinburgh has licensed an innovative gold and copper recovery process to mineral processing company Lithium Universe, enabling cleaner extraction of high‑value metals from electronic waste (e‑waste).
University of Edinburgh spinout Trogenix has announced that the first patient has been dosed in a Phase I/II clinical trial to evaluate its novel gene therapy platform targeting brain cancer.
A macrophage cell therapy that is being developed by spinout Resolution Therapeutics shows promise as the first treatment for advanced liver disease, following results from a clinical trial.
A University of Edinburgh finance graduate who taught himself to code using Chat GPT has sold his AI medical scribe Nora AI for an undisclosed sum, just two years after forming the company.
Advantage Travel Partnership has announced a strategic partnership with the Traveltech Innovation Hub at the University of Edinburgh’s Futures Institute to drive innovation and technology advancement across its global network.
No news categories with stories.
What’s your next challenge? Spin in, spin out or start up?
